News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
809,246 Results
Type
Article (74041)
Company Profile (648)
Press Release (734557)
Section
Business (227493)
Career Advice (3714)
Deals (39317)
Drug Delivery (122)
Drug Development (89288)
Employer Resources (195)
FDA (17801)
Job Trends (17110)
News (387742)
Policy (38755)
Tag
Academia (2974)
Alliances (55893)
Alzheimer's disease (1407)
Approvals (17735)
Artificial intelligence (214)
Bankruptcy (394)
Best Places to Work (12616)
Biotechnology (440)
Breast cancer (229)
Cancer (1714)
Cardiovascular disease (142)
Career advice (3159)
CAR-T (130)
Cell therapy (367)
Clinical research (71284)
Collaboration (662)
Compensation (324)
COVID-19 (2830)
C-suite (155)
Data (1554)
Diabetes (216)
Diagnostics (6774)
Earnings (92407)
Employer resources (167)
Events (126870)
Executive appointments (551)
FDA (18661)
Funding (585)
Gene therapy (259)
GLP-1 (760)
Government (5030)
Healthcare (20788)
Infectious disease (2938)
Interviews (722)
IPO (17659)
Job creations (5000)
Job search strategy (2592)
Layoffs (512)
Legal (9887)
Lung cancer (255)
Manufacturing (252)
Medical device (14479)
Medtech (14484)
Mergers & acquisitions (21950)
Metabolic disorders (596)
Neuroscience (1835)
NextGen: Class of 2025 (7630)
Non-profit (5072)
Northern California (1975)
Obesity (340)
Opinion (255)
Patents (149)
People (63520)
Pharmaceutical (136)
Phase I (22029)
Phase II (31097)
Phase III (23425)
Pipeline (663)
Postmarket research (3261)
Preclinical (9671)
Radiopharmaceuticals (262)
Rare diseases (335)
Real estate (7152)
Regulatory (25633)
Research institute (2644)
Resumes & cover letters (579)
Southern California (1721)
Startups (4191)
United States (18481)
Vaccines (697)
Weight loss (260)
Date
Last 7 days (669)
Last 30 days (2799)
Last 365 days (37287)
2025 (2881)
2024 (37906)
2023 (42567)
2022 (53926)
2021 (58723)
2020 (57667)
2019 (51309)
2018 (39088)
2017 (36854)
2016 (37777)
2015 (43761)
2014 (38468)
2013 (34452)
2012 (36348)
2011 (36468)
2010 (35931)
Location
Africa (1189)
Arizona (222)
Asia (48329)
Australia (8300)
California (4642)
Canada (1633)
China (392)
Colorado (211)
Connecticut (232)
Europe (108868)
Florida (654)
Georgia (166)
Illinois (502)
Indiana (270)
Maryland (763)
Massachusetts (3685)
Michigan (211)
Minnesota (347)
New Jersey (1312)
New York (1319)
North Carolina (941)
Northern California (1975)
Ohio (173)
Pennsylvania (1059)
South America (1565)
Southern California (1721)
Texas (686)
Utah (136)
Washington State (477)
809,246 Results for "sumitomo dainippon pharma co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Genetown
Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at the European Hematology Association (EHA) 2024 Hybrid Congress.
June 14, 2024
·
7 min read
Press Releases
Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast
January 31, 2025
·
6 min read
Business
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform is pleased to announce the successful completion of the collaborative drug discovery project with Sumitomo Pharma Co., Ltd. for rare diseases within the contractually agreed time frame.
June 23, 2023
·
3 min read
Press Releases
Sumitomo Pharma America Presents New Data on Nuvisertib and Enzomenib at the 2024 American Society of Hematology Annual Meeting
December 9, 2024
·
9 min read
Press Releases
Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia
December 23, 2024
·
8 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
Drug Development
Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting
Sumitomo Pharma America, Inc., (SMPA) today announced the presentation of data from URO-901-3005, a Phase 3 randomized, double-blind, parallel-group, fixed-dose study evaluating the efficacy, safety, and tolerability of vibegron.
May 7, 2024
·
8 min read
Press Releases
Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan
January 20, 2025
·
6 min read
Genetown
Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia
Sumitomo Pharma America, Inc. (SMPA), announced today the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for vibegron.
May 13, 2024
·
7 min read
1 of 80,925
Next
